[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Antibody Drug Conjugate Market Research Report 2018

July 2018 | 99 pages | ID: G59B053D8D5EN
QYResearch

US$ 2,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report studies the global Antibody Drug Conjugate market status and forecast, categorizes the global Antibody Drug Conjugate market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

The global Antibody Drug Conjugate market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025.

The major manufacturers covered in this report
  • Seattle Genetics/Takeda
  • Roche
  • ImmunoGen
  • Immunomedics
  • Pfizer
  • Celldex Therapeutics
  • Millennium Pharmaceuticals
  • Bayer HealthCare
  • Mersana Therapeutics
  • Heidelberg Pharma
  • Oxford BioTherapeutics
  • Takeda Pharmaceutical Company Limited
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
We can also provide the customized separate regional or country-level reports, for the following regions:
  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Indonesia
    • Singapore
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Central & South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • Turkey
    • Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Adcetris
  • Kadcyl
  • Other
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
  • Hospital
  • Pharmaceutical Company
  • Research Institutions
The study objectives of this report are:
  • To analyze and study the global Antibody Drug Conjugate sales, value, status (2013-2017) and forecast (2018-2025).
  • Focuses on the key Antibody Drug Conjugate manufacturers, to study the sales, value, market share and development plans in future.
  • Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Antibody Drug Conjugate are as follows:
  • History Year: 2013-2017
  • Base Year: 2017
  • Estimated Year: 2018
  • Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Antibody Drug Conjugate Manufacturers
Antibody Drug Conjugate Distributors/Traders/Wholesalers
Antibody Drug Conjugate Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
  • With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
  • Regional and country-level analysis of the Antibody Drug Conjugate market, by end-use.
  • Detailed analysis and profiles of additional market players.
Global Antibody Drug Conjugate Market Research Report 2018

1 ANTIBODY DRUG CONJUGATE MARKET OVERVIEW

1.1 Product Overview and Scope of Antibody Drug Conjugate
1.2 Antibody Drug Conjugate Segment by Type (Product Category)
  1.2.1 Global Antibody Drug Conjugate Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
  1.2.2 Global Antibody Drug Conjugate Production Market Share by Type (Product Category) in 2017
  1.2.3 Adcetris
  1.2.4 Kadcyl
  1.2.5 Other
1.3 Global Antibody Drug Conjugate Segment by Application
  1.3.1 Antibody Drug Conjugate Consumption (Sales) Comparison by Application (2013-2025)
  1.3.2 Hospital
  1.3.3 Pharmaceutical Company
  1.3.4 Research Institutions
1.4 Global Antibody Drug Conjugate Market by Region (2013-2025)
  1.4.1 Global Antibody Drug Conjugate Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
  1.4.2 North America Status and Prospect (2013-2025)
  1.4.3 Europe Status and Prospect (2013-2025)
  1.4.4 China Status and Prospect (2013-2025)
  1.4.5 Japan Status and Prospect (2013-2025)
  1.4.6 Southeast Asia Status and Prospect (2013-2025)
  1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Antibody Drug Conjugate (2013-2025)
  1.5.1 Global Antibody Drug Conjugate Revenue Status and Outlook (2013-2025)
  1.5.2 Global Antibody Drug Conjugate Capacity, Production Status and Outlook (2013-2025)

2 GLOBAL ANTIBODY DRUG CONJUGATE MARKET COMPETITION BY MANUFACTURERS

2.1 Global Antibody Drug Conjugate Capacity, Production and Share by Manufacturers (2013-2018)
  2.1.1 Global Antibody Drug Conjugate Capacity and Share by Manufacturers (2013-2018)
  2.1.2 Global Antibody Drug Conjugate Production and Share by Manufacturers (2013-2018)
2.2 Global Antibody Drug Conjugate Revenue and Share by Manufacturers (2013-2018)
2.3 Global Antibody Drug Conjugate Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Antibody Drug Conjugate Manufacturing Base Distribution, Sales Area and Product Type
2.5 Antibody Drug Conjugate Market Competitive Situation and Trends
  2.5.1 Antibody Drug Conjugate Market Concentration Rate
  2.5.2 Antibody Drug Conjugate Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL ANTIBODY DRUG CONJUGATE CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2013-2018)

3.1 Global Antibody Drug Conjugate Capacity and Market Share by Region (2013-2018)
3.2 Global Antibody Drug Conjugate Production and Market Share by Region (2013-2018)
3.3 Global Antibody Drug Conjugate Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Antibody Drug Conjugate Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Antibody Drug Conjugate Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Antibody Drug Conjugate Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Antibody Drug Conjugate Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Antibody Drug Conjugate Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Antibody Drug Conjugate Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Antibody Drug Conjugate Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

4 GLOBAL ANTIBODY DRUG CONJUGATE SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGION (2013-2018)

4.1 Global Antibody Drug Conjugate Consumption by Region (2013-2018)
4.2 North America Antibody Drug Conjugate Production, Consumption, Export, Import (2013-2018)
4.3 Europe Antibody Drug Conjugate Production, Consumption, Export, Import (2013-2018)
4.4 China Antibody Drug Conjugate Production, Consumption, Export, Import (2013-2018)
4.5 Japan Antibody Drug Conjugate Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Antibody Drug Conjugate Production, Consumption, Export, Import (2013-2018)
4.7 India Antibody Drug Conjugate Production, Consumption, Export, Import (2013-2018)

5 GLOBAL ANTIBODY DRUG CONJUGATE PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Antibody Drug Conjugate Production and Market Share by Type (2013-2018)
5.2 Global Antibody Drug Conjugate Revenue and Market Share by Type (2013-2018)
5.3 Global Antibody Drug Conjugate Price by Type (2013-2018)
5.4 Global Antibody Drug Conjugate Production Growth by Type (2013-2018)

6 GLOBAL ANTIBODY DRUG CONJUGATE MARKET ANALYSIS BY APPLICATION

6.1 Global Antibody Drug Conjugate Consumption and Market Share by Application (2013-2018)
6.2 Global Antibody Drug Conjugate Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL ANTIBODY DRUG CONJUGATE MANUFACTURERS PROFILES/ANALYSIS

7.1 Seattle Genetics/Takeda
  7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.1.2 Antibody Drug Conjugate Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 Seattle Genetics/Takeda Antibody Drug Conjugate Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.1.4 Main Business/Business Overview
7.2 Roche
  7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.2.2 Antibody Drug Conjugate Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 Roche Antibody Drug Conjugate Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.2.4 Main Business/Business Overview
7.3 ImmunoGen
  7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.3.2 Antibody Drug Conjugate Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 ImmunoGen Antibody Drug Conjugate Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.3.4 Main Business/Business Overview
7.4 Immunomedics
  7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.4.2 Antibody Drug Conjugate Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 Immunomedics Antibody Drug Conjugate Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.4.4 Main Business/Business Overview
7.5 Pfizer
  7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.5.2 Antibody Drug Conjugate Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 Pfizer Antibody Drug Conjugate Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
  7.5.4 Main Business/Business Overview
7.6 Celldex Therapeutics
  7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.6.2 Antibody Drug Conjugate Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 Celldex Therapeutics Antibody Drug Conjugate Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.6.4 Main Business/Business Overview
7.7 Millennium Pharmaceuticals
  7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.7.2 Antibody Drug Conjugate Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 Millennium Pharmaceuticals Antibody Drug Conjugate Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.7.4 Main Business/Business Overview
7.8 Bayer HealthCare
  7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.8.2 Antibody Drug Conjugate Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 Bayer HealthCare Antibody Drug Conjugate Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.8.4 Main Business/Business Overview
7.9 Mersana Therapeutics
  7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.9.2 Antibody Drug Conjugate Product Category, Application and Specification
    7.9.2.1 Product A
    7.9.2.2 Product B
  7.9.3 Mersana Therapeutics Antibody Drug Conjugate Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.9.4 Main Business/Business Overview
7.10 Heidelberg Pharma
  7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.10.2 Antibody Drug Conjugate Product Category, Application and Specification
    7.10.2.1 Product A
    7.10.2.2 Product B
  7.10.3 Heidelberg Pharma Antibody Drug Conjugate Capacity, Production, Revenue, Price and Gross Margin (2013-2020)
  7.10.4 Main Business/Business Overview
7.11 Oxford BioTherapeutics
7.12 Takeda Pharmaceutical Company Limited

8 ANTIBODY DRUG CONJUGATE MANUFACTURING COST ANALYSIS

8.1 Antibody Drug Conjugate Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Antibody Drug Conjugate

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Antibody Drug Conjugate Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Antibody Drug Conjugate Major Manufacturers in 2017
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL ANTIBODY DRUG CONJUGATE MARKET FORECAST (2018-2025)

12.1 Global Antibody Drug Conjugate Capacity, Production, Revenue Forecast (2018-2025)
  12.1.1 Global Antibody Drug Conjugate Capacity, Production and Growth Rate Forecast (2018-2025)
  12.1.2 Global Antibody Drug Conjugate Revenue and Growth Rate Forecast (2018-2025)
  12.1.3 Global Antibody Drug Conjugate Price and Trend Forecast (2018-2025)
12.2 Global Antibody Drug Conjugate Production, Consumption, Import and Export Forecast by Region (2018-2025)
  12.2.1 North America Antibody Drug Conjugate Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.2 Europe Antibody Drug Conjugate Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.3 China Antibody Drug Conjugate Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.4 Japan Antibody Drug Conjugate Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.5 Southeast Asia Antibody Drug Conjugate Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.6 India Antibody Drug Conjugate Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.3 Global Antibody Drug Conjugate Production, Revenue and Price Forecast by Type (2018-2025)
12.4 Global Antibody Drug Conjugate Consumption Forecast by Application (2018-2025)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology/Research Approach
  14.1.1 Research Programs/Design
  14.1.2 Market Size Estimation
  14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
  14.2.1 Secondary Sources
  14.2.2 Primary Sources
14.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Antibody Drug Conjugate
Figure Global Antibody Drug Conjugate Production () and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Antibody Drug Conjugate Production Market Share by Types (Product Category) in 2017
Figure Product Picture of Adcetris
Table Major Manufacturers of Adcetris
Figure Product Picture of Kadcyl
Table Major Manufacturers of Kadcyl
Figure Product Picture of Other
Table Major Manufacturers of Other
Figure Global Antibody Drug Conjugate Consumption (K Units) by Applications (2013-2025)
Figure Global Antibody Drug Conjugate Consumption Market Share by Applications in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Pharmaceutical Company Examples
Table Key Downstream Customer in Pharmaceutical Company
Figure Research Institutions Examples
Table Key Downstream Customer in Research Institutions
Figure Global Antibody Drug Conjugate Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2013-2025)
Figure North America Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Antibody Drug Conjugate Revenue (Million USD) Status and Outlook (2013-2025)
Figure Global Antibody Drug Conjugate Capacity, Production (K Units) Status and Outlook (2013-2025)
Figure Global Antibody Drug Conjugate Major Players Product Capacity (K Units) (2013-2018)
Table Global Antibody Drug Conjugate Capacity (K Units) of Key Manufacturers (2013-2018)
Table Global Antibody Drug Conjugate Capacity Market Share of Key Manufacturers (2013-2018)
Figure Global Antibody Drug Conjugate Capacity (K Units) of Key Manufacturers in 2017
Figure Global Antibody Drug Conjugate Capacity (K Units) of Key Manufacturers in 2018
Figure Global Antibody Drug Conjugate Major Players Product Production (K Units) (2013-2018)
Table Global Antibody Drug Conjugate Production (K Units) of Key Manufacturers (2013-2018)
Table Global Antibody Drug Conjugate Production Share by Manufacturers (2013-2018)
Figure 2017 Antibody Drug Conjugate Production Share by Manufacturers
Figure 2017 Antibody Drug Conjugate Production Share by Manufacturers
Figure Global Antibody Drug Conjugate Major Players Product Revenue (Million USD) (2013-2018)
Table Global Antibody Drug Conjugate Revenue (Million USD) by Manufacturers (2013-2018)
Table Global Antibody Drug Conjugate Revenue Share by Manufacturers (2013-2018)
Table 2017 Global Antibody Drug Conjugate Revenue Share by Manufacturers
Table 2018 Global Antibody Drug Conjugate Revenue Share by Manufacturers
Table Global Market Antibody Drug Conjugate Average Price (USD/Unit) of Key Manufacturers (2013-2018)
Figure Global Market Antibody Drug Conjugate Average Price (USD/Unit) of Key Manufacturers in 2017
Table Manufacturers Antibody Drug Conjugate Manufacturing Base Distribution and Sales Area
Table Manufacturers Antibody Drug Conjugate Product Category
Figure Antibody Drug Conjugate Market Share of Top 3 Manufacturers
Figure Antibody Drug Conjugate Market Share of Top 5 Manufacturers
Table Global Antibody Drug Conjugate Capacity (K Units) by Region (2013-2018)
Figure Global Antibody Drug Conjugate Capacity Market Share by Region (2013-2018)
Figure Global Antibody Drug Conjugate Capacity Market Share by Region (2013-2018)
Figure 2017 Global Antibody Drug Conjugate Capacity Market Share by Region
Table Global Antibody Drug Conjugate Production by Region (2013-2018)
Figure Global Antibody Drug Conjugate Production (K Units) by Region (2013-2018)
Figure Global Antibody Drug Conjugate Production Market Share by Region (2013-2018)
Figure 2017 Global Antibody Drug Conjugate Production Market Share by Region
Table Global Antibody Drug Conjugate Revenue (Million USD) by Region (2013-2018)
Table Global Antibody Drug Conjugate Revenue Market Share by Region (2013-2018)
Figure Global Antibody Drug Conjugate Revenue Market Share by Region (2013-2018)
Table 2017 Global Antibody Drug Conjugate Revenue Market Share by Region
Figure Global Antibody Drug Conjugate Capacity, Production (K Units) and Growth Rate (2013-2018)
Table Global Antibody Drug Conjugate Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table North America Antibody Drug Conjugate Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Europe Antibody Drug Conjugate Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table China Antibody Drug Conjugate Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Japan Antibody Drug Conjugate Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table China Antibody Drug Conjugate Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Japan Antibody Drug Conjugate Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Global Antibody Drug Conjugate Consumption (K Units) Market by Region (2013-2018)
Table Global Antibody Drug Conjugate Consumption Market Share by Region (2013-2018)
Figure Global Antibody Drug Conjugate Consumption Market Share by Region (2013-2018)
Figure 2017 Global Antibody Drug Conjugate Consumption (K Units) Market Share by Region
Table North America Antibody Drug Conjugate Production, Consumption, Import & Export (K Units) (2013-2018)
Table Europe Antibody Drug Conjugate Production, Consumption, Import & Export (K Units) (2013-2018)
Table China Antibody Drug Conjugate Production, Consumption, Import & Export (K Units) (2013-2018)
Table Japan Antibody Drug Conjugate Production, Consumption, Import & Export (K Units) (2013-2018)
Table Southeast Asia Antibody Drug Conjugate Production, Consumption, Import & Export (K Units) (2013-2018)
Table India Antibody Drug Conjugate Production, Consumption, Import & Export (K Units) (2013-2018)
Table Global Antibody Drug Conjugate Production (K Units) by Type (2013-2018)
Table Global Antibody Drug Conjugate Production Share by Type (2013-2018)
Figure Production Market Share of Antibody Drug Conjugate by Type (2013-2018)
Figure 2017 Production Market Share of Antibody Drug Conjugate by Type
Table Global Antibody Drug Conjugate Revenue (Million USD) by Type (2013-2018)
Table Global Antibody Drug Conjugate Revenue Share by Type (2013-2018)
Figure Production Revenue Share of Antibody Drug Conjugate by Type (2013-2018)
Figure 2017 Revenue Market Share of Antibody Drug Conjugate by Type
Table Global Antibody Drug Conjugate Price (USD/Unit) by Type (2013-2018)
Figure Global Antibody Drug Conjugate Production Growth by Type (2013-2018)
Table Global Antibody Drug Conjugate Consumption (K Units) by Application (2013-2018)
Table Global Antibody Drug Conjugate Consumption Market Share by Application (2013-2018)
Figure Global Antibody Drug Conjugate Consumption Market Share by Applications (2013-2018)
Figure Global Antibody Drug Conjugate Consumption Market Share by Application in 2017
Table Global Antibody Drug Conjugate Consumption Growth Rate by Application (2013-2018)
Figure Global Antibody Drug Conjugate Consumption Growth Rate by Application (2013-2018)
Table Seattle Genetics/Takeda Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Seattle Genetics/Takeda Antibody Drug Conjugate Capacity, Production (K Units), Revenue (Million USD), Price (Seattle Genetics/Takeda) and Gross Margin (2013-2018)
Figure Seattle Genetics/Takeda Antibody Drug Conjugate Production Growth Rate (2013-2018)
Figure Seattle Genetics/Takeda Antibody Drug Conjugate Production Market Share (2013-2018)
Figure Seattle Genetics/Takeda Antibody Drug Conjugate Revenue Market Share (2013-2018)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Antibody Drug Conjugate Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Roche Antibody Drug Conjugate Production Growth Rate (2013-2018)
Figure Roche Antibody Drug Conjugate Production Market Share (2013-2018)
Figure Roche Antibody Drug Conjugate Revenue Market Share (2013-2018)
Table ImmunoGen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table ImmunoGen Antibody Drug Conjugate Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure ImmunoGen Antibody Drug Conjugate Production Growth Rate (2013-2018)
Figure ImmunoGen Antibody Drug Conjugate Production Market Share (2013-2018)
Figure ImmunoGen Antibody Drug Conjugate Revenue Market Share (2013-2018)
Table Immunomedics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Immunomedics Antibody Drug Conjugate Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Immunomedics Antibody Drug Conjugate Production Growth Rate (2013-2018)
Figure Immunomedics Antibody Drug Conjugate Production Market Share (2013-2018)
Figure Immunomedics Antibody Drug Conjugate Revenue Market Share (2013-2018)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Antibody Drug Conjugate Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer Antibody Drug Conjugate Production Growth Rate (2013-2018)
Figure Pfizer Antibody Drug Conjugate Production Market Share (2013-2018)
Figure Pfizer Antibody Drug Conjugate Revenue Market Share (2013-2018)
Table Celldex Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Celldex Therapeutics Antibody Drug Conjugate Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Celldex Therapeutics Antibody Drug Conjugate Production Growth Rate (2013-2018)
Figure Celldex Therapeutics Antibody Drug Conjugate Production Market Share (2013-2018)
Figure Celldex Therapeutics Antibody Drug Conjugate Revenue Market Share (2013-2018)
Table Millennium Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Millennium Pharmaceuticals Antibody Drug Conjugate Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Millennium Pharmaceuticals Antibody Drug Conjugate Production Growth Rate (2013-2018)
Figure Millennium Pharmaceuticals Antibody Drug Conjugate Production Market Share (2013-2018)
Figure Millennium Pharmaceuticals Antibody Drug Conjugate Revenue Market Share (2013-2018)
Table Bayer HealthCare Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer HealthCare Antibody Drug Conjugate Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bayer HealthCare Antibody Drug Conjugate Production Growth Rate (2013-2018)
Figure Bayer HealthCare Antibody Drug Conjugate Production Market Share (2013-2018)
Figure Bayer HealthCare Antibody Drug Conjugate Revenue Market Share (2013-2018)
Table Mersana Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mersana Therapeutics Antibody Drug Conjugate Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Mersana Therapeutics Antibody Drug Conjugate Production Growth Rate (2013-2018)
Figure Mersana Therapeutics Antibody Drug Conjugate Production Market Share (2013-2018)
Figure Mersana Therapeutics Antibody Drug Conjugate Revenue Market Share (2013-2018)
Table Heidelberg Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Heidelberg Pharma Antibody Drug Conjugate Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Heidelberg Pharma Antibody Drug Conjugate Production Growth Rate (2013-2018)
Figure Heidelberg Pharma Antibody Drug Conjugate Production Market Share (2013-2018)
Figure Heidelberg Pharma Antibody Drug Conjugate Revenue Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antibody Drug Conjugate
Figure Manufacturing Process Analysis of Antibody Drug Conjugate
Figure Antibody Drug Conjugate Industrial Chain Analysis
Table Raw Materials Sources of Antibody Drug Conjugate Major Manufacturers in 2017
Table Major Buyers of Antibody Drug Conjugate
Table Distributors/Traders List
Figure Global Antibody Drug Conjugate Capacity, Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Antibody Drug Conjugate Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Antibody Drug Conjugate Price (Million USD) and Trend Forecast (2018-2025)
Table Global Antibody Drug Conjugate Production (K Units) Forecast by Region (2018-2025)
Figure Global Antibody Drug Conjugate Production Market Share Forecast by Region (2018-2025)
Table Global Antibody Drug Conjugate Consumption (K Units) Forecast by Region (2018-2025)
Figure Global Antibody Drug Conjugate Consumption Market Share Forecast by Region (2018-2025)
Figure North America Antibody Drug Conjugate Production (K Units) and Growth Rate Forecast (2018-2025)
Figure North America Antibody Drug Conjugate Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table North America Antibody Drug Conjugate Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Europe Antibody Drug Conjugate Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe Antibody Drug Conjugate Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Europe Antibody Drug Conjugate Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure China Antibody Drug Conjugate Production (K Units) and Growth Rate Forecast (2018-2025)
Figure China Antibody Drug Conjugate Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table China Antibody Drug Conjugate Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Japan Antibody Drug Conjugate Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan Antibody Drug Conjugate Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Japan Antibody Drug Conjugate Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Southeast Asia Antibody Drug Conjugate Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Antibody Drug Conjugate Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Southeast Asia Antibody Drug Conjugate Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure India Antibody Drug Conjugate Production (K Units) and Growth Rate Forecast (2018-2025)
Figure India Antibody Drug Conjugate Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table India Antibody Drug Conjugate Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Table Global Antibody Drug Conjugate Production (K Units) Forecast by Type (2018-2025)
Figure Global Antibody Drug Conjugate Production (K Units) Forecast by Type (2018-2025)
Table Global Antibody Drug Conjugate Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Antibody Drug Conjugate Revenue Market Share Forecast by Type (2018-2025)
Table Global Antibody Drug Conjugate Price Forecast by Type (2018-2025)
Table Global Antibody Drug Conjugate Consumption (K Units) Forecast by Application (2018-2025)
Figure Global Antibody Drug Conjugate Consumption (K Units) Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source


More Publications